Inequitable Conduct Ruling Survives Sanofi Fed. Circ. Appeal
A three-judge Federal Circuit panel issued a precedential opinion that rejected Aventis Pharma SA and Sanofi-Aventis U.S. LLC's challenge to a Delaware court's decision that the two Taxotere-related patents were invalid, in addition to being unenforceable due to inequitable conduct.
The Federal Circuit's May ruling in...
To view the full article, register now.